Center for Drug Evaluation and Research Prescription Drug Labeling Improvement and Enhancement Initiative; Request for Comments and Information
Title: Teva Pharmaceuticals Comment
Teva Pharmaceuticals - Comment
This is comment on Notice
Center for Drug Evaluation and Research Prescription Drug Labeling Improvement and Enhancement Initiative; Request for Comments and Information
View Comment
Attachments:
Teva Pharmaceuticals Comment
Title:
Teva Pharmaceuticals Comment
Related Comments
View AllPublic Submission Posted: 03/20/2013 ID: FDA-2013-N-0059-0010
Mar 08,2013 11:59 PM ET
Public Submission Posted: 03/20/2013 ID: FDA-2013-N-0059-0008
Mar 08,2013 11:59 PM ET
Public Submission Posted: 03/20/2013 ID: FDA-2013-N-0059-0007
Mar 08,2013 11:59 PM ET
Public Submission Posted: 03/20/2013 ID: FDA-2013-N-0059-0009
Mar 08,2013 11:59 PM ET
Public Submission Posted: 03/20/2013 ID: FDA-2013-N-0059-0003
Mar 08,2013 11:59 PM ET